Status:
UNKNOWN
Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Lower Resp Tract Infection
Human Metapneumovirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
The human metapneumovirus (hMPV) was first described in 2001. It belongs to the paramyxovirus family and is genetically close to the Respiratory Syncytial Virus (RSV). hMPV has a seasonal epidemic pat...
Detailed Description
The human metapneumovirus (hMPV) was first described in 2001. It belongs to the paramyxovirus family (paramyxoviridae subfamily). hMPV is genetically close to the Respiratory Syncytial Virus (RSV). hM...
Eligibility Criteria
Inclusion
- Adult (≥18 years old) inpatients with:
- an acute lower respiratory tract infection, defined by the presence of two of the following criteria in the 5 days preceding hospital admission or during the present hospital stay : fever, cough, expectoration, exercise or rest dyspnea, crackles, tubal breath, signs of respiratory failure (respiratory rate higher than 30 per minute...), thoracic pain, oxygen therapy, mechanical ventilation;
- a respiratory mPCR (upper respiratory tracts specimen such as nasopharyngeal swab or lower respiratory tract specimen such as tracheal or bronchial aspiration or bronchoalveolar lavage) positive for hMPV in the 5 days following hospital admission.
Exclusion
- Patient already included in the study.
Key Trial Info
Start Date :
March 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2019
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT03460171
Start Date
March 23 2018
End Date
July 31 2019
Last Update
July 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de réanimation-Hôpital Tenon
Paris, France, 75020